HYDROGEL BASED ON γ-POLYGLUTAMIC ACID AND ε-POLYLYSINE CROSSLINKED POLYMER, AND PREPARATION METHOD THEREFOR

US2017014543A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017014543-A1
Application numberUS-201315100210-A
CountryUS
Kind codeA1
Filing dateDec 28, 2013
Priority dateDec 11, 2013
Publication dateJan 19, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A hydrogel based on a cross-linked γ-polyglutamic acid and ε-polylysine polymer is obtained by cross-linking of γ-polyglutamic acid with ε-polylysine, and it is a polymer having the following constitutional unit, wherein, m is a natural number of 15 to 45, n is a natural number of 3900 to 17000, and x is a natural number of 5 to 40. It also discloses a preparation method of as-described hydrogel and its application in preparation as a medical wound dressing.

First claim

Opening claim text (preview).

What is claimed is: 1 . A hydrogel based on a cross-linked polymer of γ-polyglutamic acid and ε-polylysine, characterized in that, it is obtained by cross-linking of the γ-polyglutamic acid with the ε-polylysine, and it is a polymer having the following constitutional unit: wherein, m is a natural number of 15 to 45, n is a natural number of 3900 to 17000, and x is a natural number of 5 to 40. 2 . The hydrogel according to claim 1 , characterized in that, the γ-polyglutamic acid and ε-polylysine are obtained by microbial fermentation, respectively. 3 . The hydrogel according to claim 1 or 2 , characterized in that, molecular weight of the γ-polyglutamic acid is 500 thousand to 2.2 million Daltons, molecular weight of the ε-polylysine is 2000 to 5500 Daltons. 4 . A process for preparing a hydrogel with a γ-polyglutamic acid and a ε-polylysine, characterized in that, it comprises the following steps: (1) adding dropwisely a 2-(N-morpholino)ethanesulfonic acid buffer containing the ε-polylysine into a 2-(N-morpholino)ethanesulfonic acid buffer containing the γ-polyglutamic acid, and stirring and mixing homogeneously; (2) adding a cross-linking agent into the mixture obtained in step (1), reacting in an ice bath for 10 to 120 min, then reacting for 2 to 24 hours at room temperature to form said hydrogel; (3) placing the hydrogel formed in step (2) into a dialysis bag, and dialyzing in deionized water until swelling equilibrium, then adopting freeze drying or vacuum drying, to obtain a sponge-like dressing. 5 . The process according to claim 4 , characterized in that, in step (1), the γ-polyglutamic acid and ε-polylysine are obtained by microbial fermentation, respectively. 6 . The process according to claim 4 , characterized in that, in step (1), molecular weight of the γ-polyglutamic acid is 500 thousand to 2.2 million Daltons, molecular weight of the ε-polylysine is 2000 to 5500 Daltons. 7 . The process according to claim 4 , characterized in that, in step (1), the MES buffer is of 0.1 mol/L and pH 5.0. 8 . The process according to claim 4 , characterized in that, in step (1), the MES buffer containing the ε-polylysine is a homogeneous solution, wherein concentration of the ε-polylysine is 20 g/L to 160 g/L; the MES buffer containing γ-polyglutamic acid is a homogeneous solution, wherein mass percentage content of the γ-polyglutamic acid is 40 g/L to 200 g/L. 9 . The process according to claim 4 , characterized in that, in step (2), the cross-linking agent is selected from a group consisting of a combination of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and N-hydroxysuccinimide, a combination of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and N-hydroxysulfosuccinimide, 1-cyclohexyl-2-morpholinoethylcarbodiimide-p-toluenesulfonate and Woodward's Reagent K. 10 . The process according to claim 9 , characterized in that, in steps (2), the cross-linking agent is a combination of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and N-hydroxysuccinimide, wherein the mole ratio of carboxyl groups included in the γ-polyglutamic acid:amino groups included in the ε-polylysine:1-(3-dimethylaminopropyl)-3-ethylcarbodiimide:N-hydroxysuccinimide is 1:0.25 to 0.5:0.25 to 1:0.25 to 1. 11 . The process according to claim 9 , characterized in that, in step (2), the cross-linking agent is a combination of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and N-hydroxysulfosuccinimide, wherein the mole ratio of carboxyl groups included in the γ-polyglutamic acid:amino groups included in the ε-polylysine:1-(3-dimethylaminopropyl)-3-ethylcarbodiimide:N-hydroxysulfosuccinimide is 1:0.25 to 0.5:0.25 to 1:0.25 to 1. 12 . The process according to claim 9 , characterized in that, in step (2), the cross-linking agent is 1-cyclohexyl-2-morpholinoethylcarbodiimide-p-toluenesulfonate, wherein the mole ratio of carboxyl groups included in the γ-polyglutamic acid:amino groups included in the ε-polylysine:1-cyclohexyl-2-morpholinoethylcarbodiimide-p-toluenesulfonatebeis is 1:0.25 to 0.5:0.25 to 1. 13 . The process according to claim 9 , characterized in that, in step (2), the cross-linking agent is Woodward's Reagent K, wherein the mole ratio of carboxyl groups included in the γ-polyglutamic acid:amino groups included in the ε-polylysine:Woodward's Reagent K is 1:0.25 to 0.5:0.25 to 1. 14 . The process according to claim 4 , characterized in that, grinding and crushing the sponge-like dressing, and split charging with an aluminum composite film, a xerogel powder is yielded. 15 . The process according to claim 4 , characterized in that, adding 1 to 10 fold weight of water to the sponge-like dressing to make a soft material, split charging in a polyethylene tube, sealing and packing, the hydrogel is yielded. 16 . The process according to claim 4 , characterized in that, adding 1 to 5 fold weight of water to the sponge-like dressing to prepare a soft material, pressing into a film-coated tablet and placing onto a polyethylene film, drying by an airflow of 70 to 90.0 making its water content being 20 to 60 wt %, and laminating a polyethylene breathable film, after cutting sealing with an aluminum composite film, thereby a gel film is made. 17 . A hydrogel is prepared by the process of claim 4 . 18 . A process for preparing a medical wound dressing uses the hydrogel of claim 1 or claim 17 .

Assignees

Inventors

Classifications

  • Hydrogel, i.e. a gel containing an aqueous composition · CPC title

  • Liquid-swellable gel-forming materials, e.g. super-absorbents · CPC title

  • Sanitary use, e.g. diapers, napkins or bandages · CPC title

  • Crosslinking before of after foaming · CPC title

  • Polyamides derived from alpha-amino carboxylic acids (C08J2377/10 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017014543A1 cover?
A hydrogel based on a cross-linked γ-polyglutamic acid and ε-polylysine polymer is obtained by cross-linking of γ-polyglutamic acid with ε-polylysine, and it is a polymer having the following constitutional unit, wherein, m is a natural number of 15 to 45, n is a natural number of 3900 to 17000, and x is a natural number of 5 to 40. It also discloses a preparation method of as-described hydroge…
Who is the assignee on this patent?
Nanjing Univ Of Tech, Nanjing University Of Technology
What technology area does this patent fall under?
Primary CPC classification A61L15/26. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).